Vicor Technologies, Inc. (OTCBB: VCRT) is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i® nonlinear algorithm and software. Vicor is currently in the process of commercializing diagnostics that enable physicians to accurately risk stratify specific target populations for future pathological events, including cardiovascular disease patients for death resulting from arrhythmia or pump failure, diabetics for diabetic autonomic neuropathy (DAN), and trauma victims for imminent death absent immediate lifesaving intervention.
"Dr. Karl is a well-respected cardiologist and clinical professor whose experience and knowledge has been an asset to Vicor since he became a consultant to the Company earlier this year. We are extremely gratified to now have him serving as our Associate Medical Director on a part-time basis and as a member of our Scientific Advisory Board," stated Mr. Fater.
As Associate Medical Director, Dr. Karl will assist Dr. Daniel Weiss, Vicor's Chief Medical Officer, in developing the direction of the Company's future scientific focus and adapting that science for clinical use. He will also serve as an additional liaison, in conjunction with CEO David Fater, to the U.S. Food and Drug Administration, potential partner companies, and Vicor's clinical research organization. Additionally, Dr. Karl will assist in the oversight of Vicor's medical and clinical operations, and review/evaluate for publication all pertinent medical manuscripts and publications. Dr. Karl will also assist Dr. Edward Lundy, newly-named Chairman of the Scientific Advisory Board, as needed, with his responsibilities, which include interacting with Vicor's researchers and marketers to help identify new markets for the Company's products and serve, in conjunction with Dr. Weiss, as a spokesperson on medical affairs related to Vicor's target markets. Vicor's Scientific Advisory Board is composed of professionals in the medical, academic, and life sciences arenas.
Dr. Mitchell Scott Karl is a Boca Raton-based cardiologist and a staff cardiologist at Boca Raton Community Hospital. He is also Clinical Associate Professor of Biomedical Science at Florida Atlantic University. He has served on the staffs of Holy Cross Hospital and North Ridge Medical Center in Fort Lauderdale, West Boca Medical Center in Boca Raton, and Delray Medical Center in Delray Beach. Additionally, he was Clinical Associate Professor and, earlier, Clinical Assistant Professor of Pharmacy Practice at Nova Southeastern University. Dr. Karl served his internship, residency and cardiology fellowship training at Montifiore Medical Center of the Albert Einstein College of Medicine. Dr. Karl earned his MD at Downstate Medical Center. He holds an Executive MBA in Medical Management from Nova Southeastern Graduate School and a BA in Psychology, Summa Cum Laude, from Emory University.